Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Predictors of Pseudohypoxia-Type Pheochromocytomas.

Annals of surgical oncology - 1 Jun 2022

Baechle J J, Smith P Marincola, Ortega C A, Wang T S, Solórzano C C, Kiernan C M

Abstract excerpt

INTRODUCTION: Pheochromocytomas (PCCs) are rare tumors of neural crest origin with divergent transcriptional and metabolic profiles associated with mutational cluster types. Pseudohypoxia-type (PHT) PCCs have a poor prognosis; however diagnostic genetic testing is not always available. We aimed to investigate clinical parameters predictive of PHT PCCs. METHODS: Patients who underwent resection and genetic testing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to VHL gene
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pheochromocytoma

Share to Weight Loss

Source

Identifiers

PMID: 35233740
DOI: 10.1245/s10434-022-11419-1

Genes

VHL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Predictors of Pseudohypoxia-Type Pheochromocytomas.PMID 35233740Read ↗

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision MedicineSemantic proximity Read ↗

Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of OriginSemantic proximity Read ↗

Pseudohypoxia and family history are key predictors of severe outcomes in hereditary pheochromocytoma and paraganglioma syndromes.Semantic proximity Read ↗

New insights on the pathogenesis of paraganglioma and pheochromocytomaSemantic proximity Read ↗

Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.Semantic proximity Read ↗

Mutations of the metabolic genes IDH1, IDH2, and SDHAF2 are not major determinants of the pseudohypoxic phenotype of sporadic pheochromocytomas and paragangliomas.Semantic proximity Read ↗

The pressure rises: update on the genetics of phaeochromocytomaSemantic proximity Read ↗

PRECISION MEDICINE: AN UPDATE ON GENOTYPE/BIOCHEMICAL PHENOTYPE RELATIONSHIPS IN PHEOCHROMOCYTOMA/PARAGANGLIOMA PATIENTS.Semantic proximity Read ↗

Pheochromocytoma and paraganglioma.Semantic proximity Read ↗

The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Identification of Clinical Relevant Molecular Subtypes of Pheochromocytoma.Semantic proximity Read ↗

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/ParagangliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.